Pyoderma gangrenosum (PG) is a rare inflammatory skin disease classified within the group of neutrophilic dermatoses. Although its pathophysiology has not been fully elucidated, PG is currently regarded as an autoinflammatory process targeting the pilosebaceous unit in genetically predisposed individuals.
1 Drug-induced PG has been proposed as a model to further our understanding of the disease pathogenesis.
2